ReviewCancer medicine2026

The Keynote-177 Randomized Controlled Trial of First-line PD-1 Blockade for Microsatellite-High or Mismatch Repair-Deficient Advanced Colorectal Cancer: Potential Consequences of the Cross-Over Trial Design and Related Issues.

S L Gerritse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.